Literature DB >> 8607982

Ras-related proteins in signal transduction and growth control.

F McCormick1.   

Abstract

Ras proteins are members of a superfamily of small GTPases that are involved in many aspects of cell growth control. The ras p21 protooncogene products, H-ras, K-ras, and N-ras, transmit signals from growth factor receptors to a cascade of protein kinases that begins with the Raf protooncogene product, and leads to alterations in transcription factors and cell cycle proteins in the nucleus. This cascade is controlled at several points: Ras p21 proteins are regulated by GAPs and by exchange factors, whose activities are altered by growth factor receptor activation (Boguski and McCormick, 1993: Nature 366:643-654). Transmission of signals from Ras to Raf is regulated by the Ras-related protein Rap1 (a protein capable of reverting cell transformation) and by cAMP. Other aspects of Ras p21 regulation will be discussed, including the existence of RasGDl proteins that inhibit GDP dissociation from Ras, and may thus regulate the level of active Ras in the cell. The role of Ras in activation of Raf kinase appears to be limited to the recruitment of Raf to the plasma membrane, at which time Raf becomes stably modified to render it active (Leevers et al., 1994: Nature 369:411-414; Stokoe et al., 1994: Science 264:1463-1467). The nature of these modifications is unclear. Raf in the plasma membrane becomes associated with insoluble structural cell components that may be part of the activation. Furthermore, Raf is associated with proteins of the 14-3-3 family that appear necessary for kinase activation. The 14-3-3 proteins interact with all three conserved regions of Raf, including the kinase domain. In addition to Raf, Ras proteins interact with two known classes of proteins in a manner consistent with effector functions: these are the GAPs and regulators of the Ras-related protein Ral referred to as RalGDS. These biochemical data suggest that other functional pathways are regulated by Ras, including, perhaps, pathways involved in regulating cell shape and motility. The protein R-Ras p21 is about 50% identical to the Ras p21 protooncogene product. This protein is incapable of transforming cells, even though it interacts with Raf and other putative Ras effectors (Fernandez-Sarabia and Bischoff, 1993: Nature 366:274-275). On the other hand, it has recently been shown that R-Ras binds to the protooncogene product Bcl-2, a protein that transforms B cells by blocking apoptosis. R-Ras is regulated by the same GAP molecules as H-Ras and the other Ras protooncogene products, and may therefore be activated in a manner co-ordinate with these growth-promoting proteins. The possible connection between R-Ras and apoptosis will be discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8607982     DOI: 10.1002/mrd.1080420419

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  25 in total

1.  The small GTPase Rap1 is a novel regulator of RPE cell barrier function.

Authors:  Erika S Wittchen; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-27       Impact factor: 4.799

Review 2.  Dynamic palmitoylation and the role of DHHC proteins in T cell activation and anergy.

Authors:  Nadejda Ladygina; Brent R Martin; Amnon Altman
Journal:  Adv Immunol       Date:  2011       Impact factor: 3.543

3.  Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.

Authors:  Megan C Duggan; Kelly Regan-Fendt; Gonzalo N Olaverria Salavaggione; John Harrison Howard; Andrew R Stiff; Julia Sabella; Nicholas Latchana; Joseph Markowitz; Alejandro Gru; Susheela Tridandapani; Ann-Kathrin Eisfeld; Albert de la Chapelle; William E Carson
Journal:  Melanoma Res       Date:  2019-10       Impact factor: 3.599

4.  The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase.

Authors:  Adam I Marcus; Jun Zhou; Aurora O'Brate; Ernest Hamel; Jason Wong; Michael Nivens; Adel El-Naggar; Tso-Pang Yao; Fadlo R Khuri; Paraskevi Giannakakou
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

5.  Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene.

Authors:  M Mikula; M Schreiber; Z Husak; L Kucerova; J Rüth; R Wieser; K Zatloukal; H Beug; E F Wagner; M Baccarini
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

6.  Crosstalk between the Ras2p-controlled mitogen-activated protein kinase and cAMP pathways during invasive growth of Saccharomyces cerevisiae.

Authors:  H U Mösch; E Kübler; S Krappmann; G R Fink; G H Braus
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

7.  Detection and its implication of heat stress protein 27 and P21 in nasopharyngeal carcinoma.

Authors:  L Liu; C Xiao; Y Tao
Journal:  J Tongji Med Univ       Date:  2000

Review 8.  NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.

Authors:  I V Fedorenko; G T Gibney; K S M Smalley
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

9.  Rhes is involved in striatal function.

Authors:  Daniela Spano; Igor Branchi; Annamaria Rosica; Maria Teresa Pirro; Antonio Riccio; Pratibha Mithbaokar; Andrea Affuso; Claudio Arra; Patrizia Campolongo; Daniela Terracciano; Vincenzo Macchia; Juan Bernal; Enrico Alleva; Roberto Di Lauro
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

10.  Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure.

Authors:  Ramamoorthy Nagasubramanian; Ryan J Hansen; Shannon M Delaney; Mathew M Cherian; Leona D Samson; Scott C Kogan; M Eileen Dolan
Journal:  Mutagenesis       Date:  2008-05-13       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.